Table 2:
Screening characteristics of instruments assessing depressive symptoms using a PHQ-9 score ≥10 to identify potentially clinically significant (moderate to severe) depressive symptoms.
| Tool | Cut-off scores | Sensitivity | Specificity | TP | TN | FP | FN | PPV | NPV |
|---|---|---|---|---|---|---|---|---|---|
| ESASr-D | ≥1 | 0.75 | 0.72 | 67 | 283 | 108 | 22 | 0.38 | 0.93 |
| ≥2 | 0.71 | 0.84 | 63 | 327 | 64 | 26 | 0.50 | 0.93 | |
| PHQ-2 | ≥1 | 0.98 | 0.67 | 87 | 261 | 130 | 2 | 0.40 | 0.99 |
| ≥2 | 0.92 | 0.81 | 82 | 315 | 76 | 7 | 0.52 | 0.98 | |
| PROMIS-D | ≥53 | 0.82 | 0.77 | 73 | 301 | 90 | 16 | 0.45 | 0.95 |
| ≥55 | 0.73 | 0.85 | 65 | 333 | 58 | 24 | 0.53 | 0.93 | |
| PHQ-2 and PROMIS-D | ≥1 and ≥53 | 0.81 | 0.84 | 72 | 327 | 64 | 17 | 0.53 | 0.95 |
| ≥2 and ≥53 | 0.78 | 0.88 | 69 | 346 | 45 | 20 | 0.61 | 0.95 | |
| ≥1 and ≥55 | 0.72 | 0.87 | 64 | 342 | 49 | 25 | 0.57 | 0.93 | |
| ≥2 and ≥55 | 0.69 | 0.91 | 61 | 357 | 34 | 28 | 0.64 | 0.93 |
TP, true positive; TN, true negative; FP, false positive; FN, false negative; PPV: positive predictive value; NPV: negative predictive value.
Rows in bold indicate screening combinations with both sensitivity and specificity ≥0.80.